Ultigra 30mg Tablet
By Ultigra
Rx
10 Tablet in a Strip

Composition
Fexofenadine(30mg)

Manufacturer - Medley Pharmaceuticals
Medley House, D2, M.I.D.C. Area, Andheri (East), Mumbai-400 093, INDIA

Expires on or after
August, 2025

liver
Ultigra 30mg Tablet is considered safe for use in individuals with liver disease based on the limited available data. It appears that there may be no specific dose adjustment required for these patients. However, it is important to seek advice from your healthcare provider before starting or changing any medication regimen, including Ultigra 30mg Tablet.

kidney
Ultigra 30mg Tablet needs caution if you have kidney disease. Your doctor may adjust the dose. End-stage kidney disease patients may experience increased drowsiness.

alcohol
Consult your doctor when consuming alcohol with Ultigra 30mg Tablet.

driving
Before driving, ensure Ultigra 30mg Tablet does not cause drowsiness or dizziness. Be cautious while driving or using machinery.

pregnancy
Ultigra 30mg Tablet is not recommended during pregnancy as it may be unsafe. Animal studies have indicated potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. Kindly consult your doctor regarding its use during pregnancy.

breastfeeding
Ultigra 30mg Tablet is safe to use while breastfeeding. Studies show that the drug does not pass into breastmilk in significant amounts, posing no harm to the baby. It is unlikely to cause any adverse effects in breastfed babies due to low milk levels and absence of sedation.
Habit Forming | No |
Chemical Class | Diphenylmethane Derivative |
Therapeutic Class | RESPIRATORY |
Action Class | H1 Antihistaminics (second Generation) |
₹21
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024